Healthmonix launches 2025 MIPSpro Enterprise QCDR, expanding support for key healthcare specialties

Malvern, Pa. (Jan. 13, 2025) — Healthmonix is proud to announce the release of the 2025 MIPSpro Enterprise Qualified Clinical Data Registry (QCDR). We’ve updated this cutting-edge registry to provide comprehensive support for a wide range of healthcare specialties, helping providers improve care quality, achieve regulatory compliance, and drive better patient outcomes across various clinical settings. 

The 2025 MIPSpro Enterprise QCDR is designed to support the needs of a diverse set of healthcare specialties, making it an invaluable tool for clinicians, practices, and organizations looking to streamline operations and enhance care delivery. By leveraging this registry, healthcare providers can efficiently track and report on critical performance measures aligned with regulatory requirements and national standards. 

We also offer MIPS Cost Analytics, our industry-first software that gives providers a clear picture of the cost measures included in their Cost category score, based on their exact billing. 

Specialties supported by the 2025 MIPSpro Enterprise QCDR 

• Musculoskeletal (MSK) care: The 2025 QCDR provides tools for improving patient outcomes in musculoskeletal treatments and rehabilitation, with specific focus on functional status change following treatments. 
• Radiology: We offer a range of measures focused on the timely reporting of radiographic results and ensuring accurate interpretation of CT and PET scans. The 2025 QCDR includes measures related to coronary artery calcification and pulmonary embolism diagnosis. 
• Oncology: The 2025 QCDR facilitates high-quality imaging interpretation through oncologic FDG PET scans and quantitative criteria to improve diagnosis and treatment planning for cancer patients. 
• Cardiology: We support cardiac care with performance measures focused on coronary artery calcification reporting in CT scans, enabling early detection and intervention in heart disease management.

Driving healthcare quality and patient safety 

The 2025 MIPSpro Enterprise QCDR continues Healthmonix’s mission to support healthcare providers in improving patient care, reducing unnecessary procedures, and achieving better clinical outcomes. By focusing on the specialties that matter most, this registry offers tailored insights to help healthcare professionals refine their practices, enhance care delivery, and optimize clinical workflows. 

Through our extensive set of measures, unmatched analytics tools, and sophisticated data integrations, we’ve worked with provider groups of all sizes to realize over $700 million dollars in savings per year.  

Commitment to transforming healthcare 

Healthmonix is dedicated to advancing healthcare practices through innovative registry solutions that deliver powerful data insights. The 2025 MIPSpro Enterprise QCDR is an essential tool for clinicians who are focused on improving care quality while meeting the demands of value-based care models. 

For more information about the 2025 MIPSpro Enterprise QCDR and the specialties it supports, please visit our website or contact ngaspari@healthmonix.com.